Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
Autor Manorama Bhargavaen Limba Engleză Paperback – 15 feb 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1059.79 lei 38-44 zile | |
Springer Nature Singapore – 15 feb 2022 | 1059.79 lei 38-44 zile | |
Hardback (1) | 1070.10 lei 38-44 zile | |
Springer Nature Singapore – 14 feb 2021 | 1070.10 lei 38-44 zile |
Preț: 1059.79 lei
Preț vechi: 1115.56 lei
-5% Nou
Puncte Express: 1590
Preț estimativ în valută:
202.82€ • 213.95$ • 169.51£
202.82€ • 213.95$ • 169.51£
Carte tipărită la comandă
Livrare economică 27 decembrie 24 - 02 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789813348011
ISBN-10: 9813348011
Pagini: 246
Ilustrații: XXVI, 246 p. 232 illus., 114 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.64 kg
Ediția:1st ed. 2021
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
ISBN-10: 9813348011
Pagini: 246
Ilustrații: XXVI, 246 p. 232 illus., 114 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.64 kg
Ediția:1st ed. 2021
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
Cuprins
Section I Cytogenetic
Chapter 1: Techniques in cytoenetics (Karotyping and FISH)
Chapter 2:Case studies in Acute Myeloid Leukemia
Chapter 3:Case studies in Acute Lymphoblastic leukemia
Chapter 4:Case studies in Chronic Myeloid Leukemia
Chapter 5:Case studies in Myelodys Plastic Syndrome
Chapter 6:Case studies on FISH in Chronic Lymphocytic Leukemia
Chapter 7:Case studies on FISH in Multiple Myeloma
Section II Molecular Hematology
Chapter 1: Techniques in Molecular Hematology
Chapter 2:Case studies in Chronic Myeloid LeukemiaChapter 3:Case studies in Acute Myeloid Leukemia
Chapter 4:Case studies in Acute Lymphoblastic leukemia)
Chapter 5:Case studies in Myeloproliferative Neoplasms
Recenzii
Notă biografică
Dr. Bhargava has served as a Professor and Head, Department of Hematology at the prestigious All India Institute of Medical Sciences until September 2001, Sir Ganga Ram Hospital till 2016 and as Senior Advisor and Head Hematopathology at Medanta, The Medicity until May 2020.
Dr. Bhargava is a pioneer in Hematology in India and is widely recognised for her contributions to Hematology both nationally and internationally. In a career spanning almost 50 years, she advocated and brought awareness for hematology as a discipline separate from Internal Medicine and Pathology where it constituted a minor part. Recipient of prestigious fellowships such as Alexander Von Humboldt, Fogarty and INSA fellowships. She has been principal investigator on several research grants, notably Indo-US, Indo-French, Indo–German and Indo-Japan grants and has published more than 300 articles in national and international journals.
In recognition of her contributions to Hematology, she was awarded the Dr. B.C. Roy National Award and the highest award of Indian Council of Medical Research, the Basanti Devi Amirchand prize. An acclaimed teacher, she established the first ever superspecialty degrees of DM in clinical Hematology and DM in Hematapathology in the year 2000 at the All India Institute of Medical Sciences and the Diplomate National Board in Hematology in 2008.
Dr. Bhargava is a pioneer in Hematology in India and is widely recognised for her contributions to Hematology both nationally and internationally. In a career spanning almost 50 years, she advocated and brought awareness for hematology as a discipline separate from Internal Medicine and Pathology where it constituted a minor part. Recipient of prestigious fellowships such as Alexander Von Humboldt, Fogarty and INSA fellowships. She has been principal investigator on several research grants, notably Indo-US, Indo-French, Indo–German and Indo-Japan grants and has published more than 300 articles in national and international journals.
In recognition of her contributions to Hematology, she was awarded the Dr. B.C. Roy National Award and the highest award of Indian Council of Medical Research, the Basanti Devi Amirchand prize. An acclaimed teacher, she established the first ever superspecialty degrees of DM in clinical Hematology and DM in Hematapathology in the year 2000 at the All India Institute of Medical Sciences and the Diplomate National Board in Hematology in 2008.
Textul de pe ultima copertă
This book is a compendium of case studies in hematologic malignancies such as acute leukemias, myelodysplastic and myeloproliferative neoplasms, chronic leukemias and multiple myeloma covering cytogenetics (karyotyping Fluorescence in sitn hybridization (FISH)) and molecular studies in detail. The first few chapters describe the methodology employed for karyotyping, FISH and Real Time PCR technology conducive to establishment of these labs if required. Each case study is described in detail by including the clinical history of the patient, findings of peripheral blood, bone marrow aspirate and bone biopsy morphological details. This is then followed by flowcytometric immunophenotyping, cytogenetic and molecular observations leading collectively to a final diagnosis, A discussion follows based on the relevance of this data in informing the prognosis, treatment response and survival in these patients. Additionally, this data serves as a key determinant for clinical decision making involving evidence based rational management of patients including targeted therapy. For better understanding, each case study is accompanied by black and white or colour images as appropriate. This book is a source of learning and a valuable read for clinical hematologists, hematopathologists, medical oncologists, residents, interns, DM Hematology students and DNB Hematology students as well.
Caracteristici
Explains the significance of the results obtained towards the prognosis and treatment response
Presents several case studies in hematologic malignancies with particular reference to cytogenetics
Describes a vision of future development towards enhancing diagnosis and application of targeted therapies
Presents several case studies in hematologic malignancies with particular reference to cytogenetics
Describes a vision of future development towards enhancing diagnosis and application of targeted therapies